XTX Topco Ltd Has $941,000 Stake in Moelis & Company (NYSE:MC)

XTX Topco Ltd trimmed its position in Moelis & Company (NYSE:MC) by 16.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,736 shares of the asset manager’s stock after selling 2,788 shares during the quarter. XTX Topco Ltd’s holdings in Moelis & Company were worth $941,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Reston Wealth Management LLC acquired a new position in shares of Moelis & Company in the third quarter valued at $26,000. UMB Bank n.a. grew its position in Moelis & Company by 63.5% in the second quarter. UMB Bank n.a. now owns 497 shares of the asset manager’s stock valued at $28,000 after acquiring an additional 193 shares during the period. GAMMA Investing LLC grew its position in Moelis & Company by 115.8% in the third quarter. GAMMA Investing LLC now owns 995 shares of the asset manager’s stock valued at $68,000 after acquiring an additional 534 shares during the period. Blue Trust Inc. grew its position in Moelis & Company by 193.0% in the third quarter. Blue Trust Inc. now owns 1,081 shares of the asset manager’s stock valued at $74,000 after acquiring an additional 712 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. bought a new stake in Moelis & Company in the third quarter valued at $75,000. 91.53% of the stock is currently owned by institutional investors and hedge funds.

Moelis & Company Stock Performance

Shares of MC stock opened at $73.58 on Wednesday. The stock’s fifty day moving average is $72.03 and its 200-day moving average is $65.38. The stock has a market capitalization of $5.51 billion, a PE ratio of 138.83 and a beta of 1.37. Moelis & Company has a 52 week low of $46.24 and a 52 week high of $81.60.

Moelis & Company (NYSE:MC) last announced its earnings results on Wednesday, October 23rd. The asset manager reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. The company had revenue of $273.76 million for the quarter, compared to analysts’ expectations of $273.58 million. Moelis & Company had a return on equity of 12.15% and a net margin of 4.22%. The business’s revenue for the quarter was up .6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.15) earnings per share. As a group, analysts forecast that Moelis & Company will post 0.97 earnings per share for the current fiscal year.

Moelis & Company Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 2nd. Investors of record on Monday, November 4th were given a $0.60 dividend. The ex-dividend date was Monday, November 4th. This represents a $2.40 dividend on an annualized basis and a yield of 3.26%. Moelis & Company’s payout ratio is 452.83%.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Wells Fargo & Company assumed coverage on Moelis & Company in a research report on Thursday, September 12th. They issued an “equal weight” rating and a $70.00 price target on the stock. Morgan Stanley upgraded Moelis & Company from an “underweight” rating to an “overweight” rating and upped their price target for the company from $66.00 to $92.00 in a research report on Monday. Finally, UBS Group upped their price target on Moelis & Company from $54.00 to $60.00 and gave the company a “sell” rating in a research report on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $65.17.

About Moelis & Company

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.